Skip to content

PharmaSave

Active Private limited companyfounded 2017active for 9 yearsOudebaan 61, 2610 AntwerpKBO/BCE: BE 0677.769.484 subsidiary of Abacus Medicine A/S
PharmaSave
Follow ReportCompare

Board

1 director
Felmming Wagner
Director
since 30-06-2017
listed in the 2025 annual accounts, filed on 14-09-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 02-10-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Felmming Wagner
Director
Board
Mandates as a list
  • Felmming Wagner
    • Director, from 30-06-2017 to date

Control

Consolidating parent
Abacus Medicine A/S DK
Source: parent in own accounts 2025
consolidates
This company
PharmaSave
Equity €10,974
Profit €667 in 2025

Capital

Contribution
€12,400
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Abacus Medicine A/S DK
consolidates
consolidates
Owners as a list

Source: parent in its own accounts

Articles of association

deed of 02-10-2026 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
15 April at 18:00

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure